Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hot Flashes × fezolinetant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Hot Flashes 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

Acupuncture Therapy 8 Venlafaxine Hydrochloride 5 Gabapentin 5 Isoflavones 3 Bupivacaine 3 black cohosh root extract 2 Tamoxifen 2 Soybean Proteins 2 Sodium Chloride 2 Moxifloxacin 2 Magnesium Oxide 2 Estrogens, Conjugated (USP) 2 Control Groups 2 Citalopram 2 zopiclone 1 liposomal amphotericin B 1 fezolinetant 1 bazedoxifene 1 Zolpidem 1 Vancomycin 1 Therapeutics 1 Testosterone 1 Tazobactam 1 Tablets 1 Sugars 1 Solifenacin Succinate 1 Sertraline 1 Pregabalin 1 Piperacillin, Tazobactam Drug Combination 1 Piperacillin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06972875 2026-02-05

FLASH

University of Vermont

Phase 2 Recruiting

Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡